Thromb Haemost 1998; 79(06): 1214-1215
DOI: 10.1055/s-0037-1615043
Letters to the Editor
Schattauer GmbH

Prothrombin 20210A Polymorphism and Third Generation Oral Contraceptives – A Case Report of Coeliac Axis Thrombosis and Splenic Infarction

J. Gould
1   Department of Haematology, University Hospital Nottingham, Nottingham, UK
,
S. Deam
1   Department of Haematology, University Hospital Nottingham, Nottingham, UK
,
G. Dolan
1   Department of Haematology, University Hospital Nottingham, Nottingham, UK
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 13. Januar 1998

Accepted after revision 12. Februar 1998

Publikationsdatum:
07. Dezember 2017 (online)

 

 
  • References

  • 1 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.. Blood 1996; 88 (10) 3698-703.
  • 2 Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR. The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population.. Br J Haemat 1998; 98 (Suppl. 02) 353-5.
  • 3 Hannaford PC. Combined oral contraceptive use and venous thromboembolism.. Gynecol Endocrinol 1996; (Suppl. 02) 13-8.
  • 4 Spitzer WO, Lewis MA, Heinemann LAJ. et al. On behalf of Transnational Research Group on Oral Contraceptives and the Health of Young Women. Third generation oral contraceptives and the risk of venous thromboembolic disorders: an international case control study.. Br Med J 1996; 312: 83-8.